Health-related outcomes associated with tapentadol extended release (ER) treatment for the management of painful diabetic peripheral neuropathy (DPN): results of a randomized-withdrawal phase 3 trial
| Autor: | Etropolski, M., Kleinert, R., Shapiro, D.Y., Okamoto, A., Lange, R., Rauschkolb, C. |
|---|---|
| Zdroj: | In Canadian Journal of Diabetes 2009 33(3):193-193 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect